Neoadjuvant Atezolizumab in Cutaneous Melanoma

NCT04020809 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Melanoma

Interventions

DRUG: Atezolizumab

Sponsor

The Methodist Hospital Research Institute

Collaborators

Genentech, Inc.